Cited by 1,423CRISPR and Genetic EngineeringBacterial Genetics and BiotechnologyRNA regulation and disease

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Diversity, classification and evolution of CRISPR-Cas systems

Open access

Koonin, Eugene V, Makarova, Kira S, Zhang, Feng·2017·Current Opinion in Microbiology

DOI 10.1016/j.mib.2017.05.008PMC PMC5776717

Open this paper in CoChat — free account

Abstract

The bacterial and archaeal CRISPR-Cas systems of adaptive immunity show remarkable diversity of protein composition, effector complex structure, genome locus architecture and mechanisms of adaptation, pre-CRISPR (cr)RNA processing and interference. The CRISPR-Cas systems belong to two classes, with multi-subunit effector complexes in Class 1 and single-protein effector modules in Class 2. Concerted genomic and experimental efforts on comprehensive characterization of Class 2 CRISPR-Cas systems led to the identification of two new types and several subtypes. The newly characterized type VI systems are the first among the CRISPR-Cas variants to exclusively target RNA. Unexpectedly, in some of the class 2 systems, the effector protein is additionally responsible for the pre-crRNA processing. Comparative analysis of the effector complexes indicates that Class 2 systems evolved from mobile genetic elements on multiple, independent occasions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mib.2017.05.008

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Self-citation
Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
Self-citation
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
Self-citation
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citation
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
Self-citation
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016) · Nature · doi:10.1038/nature19802 · Cited by 1,236
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Self-citation

Flagged first, then by citations

Show all 73 references

Sorted by citations

Items 301–400 of 999

The Battle between Bacteria and Bacteriophages: A Conundrum to Their Immune System
Teklemariam, A. D., Al-Hindi, R. R., Qadri, I., Alharbi, M. G., Ramadan, W. S., Ayubu, J., Al-Hejin, A. M., Hakim, R. F., Hakim, F. F., Hakim, R. F., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12020381 · Cited by 52
Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity
Wang, L., Mo, C. Y., Wasserman, M. R., Rostøl, J. T., Marraffini, L. A., & Liu, S. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.008 · Cited by 52
Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells
Cui, J., Techakriengkrai, N., Nedumpun, T., & Suradhat, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-66775-3 · Cited by 52
Recent Progress and Challenges in CRISPR-Cas9 Engineered Algae and Cyanobacteria
Patel, V. K., Das, A., Kumari, R., & Kajla, S. (2023) · Algal Research · doi:10.1016/j.algal.2023.103068 · Cited by 50
Microbial Arsenal of Antiviral Defenses. Part II
Isaev, A. B., Musharova, O. S., & Severinov, K. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921040064 · Cited by 51
Genomes of six viruses that infect Asgard archaea from deep-sea sediments
Rambo, I. M., Langwig, M. V., Leão, P., Anda, V. D., & Baker, B. J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01150-8 · Cited by 54
Lateral flow biosensor based on LAMP-CRISPR/Cas12a for sensitive and visualized detection of Salmonella spp.
Lee, S., & Oh, S. (2022) · Food Control · doi:10.1016/j.foodcont.2022.109494 · Cited by 51
CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Javed, M. U., Hayat, M. T., Mukhtar, H., & Imre, K. (2023) · Antibiotics · doi:10.3390/antibiotics12061075 · Cited by 55
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Apostolopoulos, A., Kawamoto, N., Chow, S. Y. A., Tsuiji, H., Ikeuchi, Y., Shichino, Y., & Iwasaki, S. (2024) · Nature Communications · doi:10.1038/s41467-024-46412-7 · Cited by 52
Implementation of a CRISPR-Based System for Gene Regulation in Candida albicans
Román, E., Coman, I., Prieto, D., Alonso‐Monge, R., & Plá, J. (2019) · mSphere · doi:10.1128/msphere.00001-19 · Cited by 49
CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage
Common, J., Morley, D., Westra, E. R., & van Houte, S. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0098 · Cited by 48
Cell-autonomous immunity by IFN-induced GBPs in animals and plants
Huang, S., Meng, Q., Mamińska, A., & MacMicking, J. D. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.04.017 · Cited by 47
Cas12a trans-cleavage can be modulated in vitro and is active on ssDNA, dsDNA, and RNAPreprint
Fuchs, R. T., Curcuru, J. L., Mabuchi, M. Y., Yourik, P., & Robb, G. B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/600890 · Cited by 50
Study the Features of 57 Confirmed CRISPR Loci in 38 Strains of Staphylococcus aureus
Zhao, X., Yu, Z., & Xu, Z. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01591 · Cited by 51
Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules
Shams, A., Higgins, S. A., Fellmann, C., Laughlin, T. G., Oakes, B. L., Lew, R., Kim, S., Lukarska, M., Arnold, M. L., Staahl, B. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25992-8 · Cited by 50
Clinical applications of CRISPR‐based genome editing and diagnostics
Foss, D. V., Hochstrasser, M. L., & Wilson, R. C. (2019) · Transfusion · doi:10.1111/trf.15126 · Cited by 51
AcrIIA5 Inhibits a Broad Range of Cas9 Orthologs by Preventing DNA Target Cleavage
Song, G., Zhang, F., Zhang, X., Gao, X., Zhu, X., Fan, D., & Tian, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.078 · Cited by 49
Self-citation
Probiotics and Trained Immunity
Cortes‐Perez, N. G., de LeBlanc, A. D. M., Gómez-Gutiérrez, J. G., LeBlanc, J. G., & Bermúdez‐Humarán, L. G. (2021) · Biomolecules · doi:10.3390/biom11101402 · Cited by 53
Recent advances of Cas12a applications in bacteria
Meliawati, M., Schilling, C., & Schmid, J. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11243-9 · Cited by 51
Designing Allele-Specific Competitive-Extension PCR-Based Assays for High-Throughput Genotyping and Gene Characterization
Kalendar, R. N., Shustov, A. V., Akhmetollayev, I. A., & Kairov, U. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.773956 · Cited by 49
Recent advances in CRISPR‐based systems for the detection of foodborne pathogens
Shin, J., Miller, M. J., & Wang, Y. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12956 · Cited by 51
Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches
Yin, Y., Yang, B., & Entwistle, S. (2019) · mSystems · doi:10.1128/msystems.00455-19 · Cited by 49
CRISPR-based enrichment strategies for targeted sequencing
Schultzhaus, Z. S., Wang, Z., & Stenger, D. A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107672 · Cited by 47
Versatile Applications of the CRISPR/Cas Toolkit in Plant Pathology and Disease Management
Wheatley, M. S., & Yang, Y. (2020) · Phytopathology · doi:10.1094/phyto-08-20-0322-ia · Cited by 50
Blackjack mutations improve the on-target activities of increased fidelity variants of SpCas9 with 5′ G-extended sgRNAs
Kulcsár, P. I., Tálas, A., Tóth, E., Nyeste, A., Ligeti, Z., Welker, Z., & Welker, E. (2020) · Nature Communications · doi:10.1038/s41467-020-15021-5 · Cited by 45
CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria
Call, S. N., & Andrews, L. B. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892304 · Cited by 49
Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens
Wang, R., Shu, X., Zhao, H., Xue, Q., Liu, C., Wu, A., Cheng, F., Wang, L., Zhang, Y., Feng, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37789-y · Cited by 49
The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance
Shang, Z., Chan, S. Y., Song, Q., Li, P., & Huang, W. (2020) · Research · doi:10.34133/2020/2016201 · Cited by 49
Recent advances in genome editing of stem cells for drug discovery and therapeutic application
Lee, J., Bayarsaikhan, D., Bayarsaikhan, G., Kim, J., Schwarzbach, E., & Lee, B. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107501 · Cited by 48
Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
Bhattacharya, S., & Satpati, P. (2022) · ACS Omega · doi:10.1021/acsomega.2c05583 · Cited by 51
A game of resistance: War between bacteria and phages and how phage cocktails can be the solution
Costa, P., Pereira, C., Romalde, J. L., & Almeida, A. (2024) · Virology · doi:10.1016/j.virol.2024.110209 · Cited by 49
Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor
Kim, I., Jeong, M., Ka, D., Han, M., Kim, N., Bae, E., & Suh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22177-0 · Cited by 45
Highly Sensitive Immuno-CRISPR Assay for CXCL9 Detection
Lee, I., Kwon, S., Sorci, M., Heeger, P. S., & Dordick, J. S. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03705 · Cited by 47
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
El‐Mowafy, M., Elgaml, A., El‐Mesery, M., Sultan, S., Ahmed, T. A., Gomaa, A. I., Aly, M., & Mottawea, W. (2021) · Biology · doi:10.3390/biology10010055 · Cited by 48
Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence
Babu, K., Kathiresan, V., Kumari, P., Newsom, S. N., Parameshwaran, H. P., Chen, X., Liu, J., Qin, P. Z., & Rajan, R. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00354 · Cited by 46
CRISPR/Cas13a combined with hybridization chain reaction for visual detection of influenza A (H1N1) virus
Zhou, H., Bu, S., Xu, Y., Xue, L., Li, Z., Hao, Z., Wan, J., & Tang, F. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04380-1 · Cited by 45
CRISPR-Cas target recognition for sensing viral and cancer biomarkers
Rahimi, S., Balusamy, S. R., Perumalsamy, H., Ståhlberg, A., & Mijakovic̀, I. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae736 · Cited by 49
cas9 Enhances Bacterial Virulence by Repressing the regR Transcriptional Regulator in Streptococcus agalactiae
Ma, K., Cao, Q., Luo, S., Wang, Z., Liu, G., Lu, C., & Liu, Y. (2017) · Infection and Immunity · doi:10.1128/iai.00552-17 · Cited by 45
Comparative genomics and evolution of trans-activating RNAs in Class 2 CRISPR-Cas systems
Faure, G., Shmakov, S., Makarova, K. S., Wolf, Y. I., Crawley, A. B., Barrangou, R., & Koonin, E. V. (2018) · RNA Biology · doi:10.1080/15476286.2018.1493331 · Cited by 47
Self-citation
Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance
Babu, K., Amrani, N., Jiang, W., Yogesha, S. D., Nguyen, R., Qin, P. Z., & Rajan, R. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01241 · Cited by 47
CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool
Sahel, D. K., Mittal, A., & Chitkara, D. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257287 · Cited by 47
Multiplex genome editing using a dCas9-cytidine deaminase fusion in Streptomyces
Zhao, Y., Tian, J., Zheng, G., Chen, J., Sun, C., Yang, Z., Zimin, A. A., Jiang, W., Deng, Z., Wang, Z., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1559-y · Cited by 50
Targeted mutagenesis in Arabidopsis thaliana using CRISPR‐Cas12b/C2c1
Wu, F. H., Qiao, X., Zhao, Y., Zhang, Z., Gao, Y., Shi, L., Du, H., Wang, L., Zhang, Y., Zhang, Y., et al. (2020) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12944 · Cited by 46
Conditional guide RNA through two intermediate hairpins for programmable CRISPR/Cas9 function: building regulatory connections between endogenous RNA expressions
Lin, J., Liu, Y., Lai, P., Ye, H., & Xu, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa842 · Cited by 46
Genomic and Phenotypic Analysis of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates Carrying Different Types of CRISPR/Cas Systems
Tyumentsev, A. I., Mikhaylova, Y., Prelovskaya, A., Tyumentsev, A. I., Petrova, L., Fomina, V., Zamyatin, M. N., Shelenkov, A. A., & Акимкин, В. Г. (2021) · Pathogens · doi:10.3390/pathogens10020205 · Cited by 48
Putting CRISPR-Cas system in action: a golden window for efficient and precise genome editing for crop improvement
Tariq, A., Mushtaq, M., Yaqoob, H., Bhat, B. A., Zargar, S. M., Raza, A., Ali, S., Charagh, S., Mubarik, M. S., Zaman, Q. U., et al. (2023) · GM Crops & Food · doi:10.1080/21645698.2023.2219111 · Cited by 45
Comparative in silico genome analysis of Clostridium perfringens unravels stable phylogroups with different genome characteristics and pathogenic potential
Abdel‐Glil, M. Y., Thomas, P., Linde, J., Busch, A., Wieler, L. H., Neubauer, H., & Seyboldt, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-86148-8 · Cited by 45
Advances in genomics and genome editing for breeding next generation of fruit and nut crops
Savadi, S., Mangalassery, S., & Sandesh, M. S. (2021) · Genomics · doi:10.1016/j.ygeno.2021.09.001 · Cited by 47
CRISPR Cas system: A strategic approach in detection of nucleic acids
Fapohunda, F. O., Huang, D., Qiu, S., Qiao, S., Pan, Y., Shi, S., Wang, H., & Lü, P. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127000 · Cited by 46
Recent advancements in CRISPR/Cas technology for accelerated crop improvement
Das, D., Singha, D. L., Paswan, R. R., Chowdhury, N., Sharma, M., Reddy, P. S., & Chikkaputtaiah, C. (2022) · Planta · doi:10.1007/s00425-022-03894-3 · Cited by 50
CRISPR-Cas systems mediated biosensing and applications in food safety detection
Liu, J., Wu, D., Chen, J., Jia, S., Chen, J., Wu, Y., & Li, G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2128300 · Cited by 45
CRISPR/Cas-Based Diagnostics in Agricultural Applications
Tanny, T., Sallam, M., Soda, N., Nguyen, N., Alam, M. M., & Shiddiky, M. J. A. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00913 · Cited by 47
Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins
Zhu, Y., Zhang, F., & Huang, Z. (2018) · BMC Biology · doi:10.1186/s12915-018-0504-9 · Cited by 47
Self-citation
CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology
Koonin, E. V. (2019) · Biology & Philosophy · doi:10.1007/s10539-018-9658-7 · Cited by 44
Self-citation
Potential applications of CRISPR/Cas for next-generation biomonitoring of harmful algae blooms: A review
Durán‐Vinet, B., Araya‐Castro, K., Chao, T., Wood, S., Gallardo, V., Godoy, K., & Abanto, M. (2021) · Harmful Algae · doi:10.1016/j.hal.2021.102027 · Cited by 45
Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1
Zhang, B., Luo, D., Li, Y., Perčulija, V., Chen, J., Lin, J., Ye, Y., & Ouyang, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23876-5 · Cited by 44
CRISPR-Cas12a-Based Diagnostics of Wheat Fungal Diseases
Mu, K., Ren, X., Yang, H., Zhang, T., Yan, W., Yuan, F., Wu, J., Kang, Z., Han, D., Deng, R., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c08391 · Cited by 45
Rapid and sensitive detection of two fungal pathogens in soybeans using the recombinase polymerase amplification/ CRISPR‐Cas12a method for potential on‐site disease diagnosis
Sun, X., Lei, R., Zhang, H., Chen, W., Jia, Q., Guo, X., Zhang, Y., Wu, P., & Wang, X. (2023) · Pest Management Science · doi:10.1002/ps.7847 · Cited by 44
CRISPR enables sustainable cereal production for a greener future
Ahmar, S., Usman, B., Hensel, G., Jung, K., & Gruszka, D. (2023) · Trends in Plant Science · doi:10.1016/j.tplants.2023.10.016 · Cited by 46
Tuning CRISPR-Cas9 Gene Drives in Saccharomyces cerevisiae
Roggenkamp, E., Giersch, R. M., Schrock, M. N., Turnquist, E., Halloran, M., & Finnigan, G. C. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300557 · Cited by 45
The nuts and bolts of the Haloferax CRISPR-Cas system I-B
Maier, L., Stachler, A.-E., Brendel, J., Stoll, B., Fischer, S. M., Haas, K. A., Schwarz, T. S., Alkhnbashi, O. S., Sharma, K., Urlaub, H., et al. (2018) · RNA Biology · doi:10.1080/15476286.2018.1460994 · Cited by 44
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Chou-Zheng, L., & Hatoum-Aslan, A. (2019) · eLife · doi:10.7554/elife.45393 · Cited by 44
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
Zhang, F., Song, G., & Tian, Y. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12069 · Cited by 44
Self-citation
Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path
Jia, N., Jones, R. A., Sukenick, G. D., & Patel, D. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.013 · Cited by 42
High efficiency CRISPR/Cas9 genome editing system with an eliminable episomal sgRNA plasmid in Pichia pastoris
Yang, Y., Liu, G., Chen, X., Liu, M., Zhan, C., Liu, X., & Bai, Z. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109556 · Cited by 44
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
Yan, J., Kang, D. D., Turnbull, G., & Dong, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114042 · Cited by 45
CRISPR-Cas system meets DNA barcoding: Development of a universal nucleic acid test for food authentication
Wu, Y., Liu, J., Li, H., Zhang, T., Dong, Y., Deng, S., Lv, Y., He, Q., & Deng, R. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.131138 · Cited by 44
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Baghini, S. S., Gardanova, Z. R., Abadi, S. A. H., Zaman, B. A., İlhan, A., Shomali, N., Adili, A., Moghaddar, R., & Yaseri, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00336-6 · Cited by 46
CRISPR-Based Genome Editing and Its Applications in Woody Plants
Min, T., Hwarari, D., Li, D., Movahedi, A., & Yang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710175 · Cited by 49
Rapid detection of SARS-CoV-2: The gradual boom of lateral flow immunoassay
He, J., Zhu, S., Zhou, J., Jiang, W., Yin, L., Su, L., Zhang, X., Chen, Q., & Li, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1090281 · Cited by 44
CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection
Razavi, Z.-S., Soltani, M., Pazoki–Toroudi, H., & Chen, P. (2024) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2024.115625 · Cited by 44
Cas4–Cas1 fusions drive efficient PAM selection and control CRISPR adaptation
Almendros, C., Nóbrega, F. L., McKenzie, R. E., & Brouns, S. J. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz217 · Cited by 43
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
Raaijmakers, R. H. L., Ripken, L., Ausems, C. R. M., & Wansink, D. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153689 · Cited by 46
Structural basis for inhibition of the type I-F CRISPR–Cas surveillance complex by AcrIF4, AcrIF7 and AcrIF14
Gabel, C. A., Li, Z., Zhang, H., & Chang, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1199 · Cited by 43
Induced Genetic Variations in Fruit Trees Using New Breeding Tools: Food Security and Climate Resilience
Sattar, M. N., Iqbal, Z., Al-Khayri, J. M., & Jain, S. M. (2021) · Plants · doi:10.3390/plants10071347 · Cited by 45
A Cas3-base editing tool for targetable in vivo mutagenesis
Zimmermann, A., Prieto-Vivas, J. E., Cautereels, C., Gorkovskiy, A., Steensels, J., de Peer, Y. V., & Verstrepen, K. J. (2023) · Nature Communications · doi:10.1038/s41467-023-39087-z · Cited by 45
Reprogrammable RNA-targeting CRISPR systems evolved from RNA toxin-antitoxins
Zilberzwige‐Tal, S., Altae-Tran, H., Kannan, S., Wilkinson, M. E., Vo, C.-D.-T., Strebinger, D., Edmonds, K. K., Yao, C.-C. J., Mears, K. S., Shmakov, S., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.034 · Cited by 47
Self-citation
Genome-wide mapping reveals conserved and diverged R-loop activities in the unusual genetic landscape of the African trypanosome genome
Briggs, E. M., Hamilton, G. M., Crouch, K., Lapsley, C. T., & McCulloch, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky928 · Cited by 42
How to Train Your Phage: The Recent Efforts in Phage Training
Abdelsattar, A. S., Dawoud, A., Rezk, N., Makky, S., Safwat, A., Richards, P., & El‐Shibiny, A. (2021) · Biologics · doi:10.3390/biologics1020005 · Cited by 42
Genome-editing strategies for treating human retinal degenerations
Quinn, J., Musa, A., Kantor, A., McClements, M. E., Cehajic-Kapetanovic, J., MacLaren, R. E., & Xue, K. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.231 · Cited by 41
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 43
The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity
Chevallereau, A., Meaden, S., van Houte, S., Westra, E. R., & Rollie, C. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0094 · Cited by 40
Novel genetic therapeutic approaches for modulating the severity of β‑thalassemia (Review)
Amjad, F., Fatima, T., Fayyaz, T., Khan, M. J., & Qadeer, M. I. (2020) · Biomedical Reports · doi:10.3892/br.2020.1355 · Cited by 43
Molecular Reporters for Crispr/Cas: From Design Principles to Engineering for Bioanalytical and Diagnostic Applications
Sohail, M., Qin, L., Li, S., Chen, Y., Zaman, M. H., Zhang, X., Li, B., & Huang, H. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116539 · Cited by 42
CRISPR/Cas9 technology and its application in horticultural crops
Liu, Y., Zhang, C., Wang, X., Li, X., & You, C. (2022) · Horticultural Plant Journal · doi:10.1016/j.hpj.2022.04.007 · Cited by 41
CRISPR-Cas based molecular diagnostics for foodborne pathogens
Lu, Y., Yang, H., Bai, J., He, Q., & Deng, R. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153792 · Cited by 39
Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42
Mycobacterium tuberculosis type III‐A CRISPR/Cas system crRNA and its maturation have atypical features
Wei, W., Zhang, S., Fleming, J., Chen, Y., Li, Z., Fan, S., Liu, Y., Wang, W., Wang, T., Liu, Y., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800557rr · Cited by 40
Comparative Genomics Analysis of Lactobacillus mucosae from Different Niches
Jia, Y., Yang, B. K., Ross, R. P., Stanton, C., Zhang, H., Zhao, J., & Chen, W. (2020) · Genes · doi:10.3390/genes11010095 · Cited by 42
Co-evolution of mutagenic genome editors and vertebrate adaptive immunity
Trancoso, I., Morimoto, R., & Boehm, T. L. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.03.001 · Cited by 41
Characterization of Cme and Yme thermostable Cas12a orthologs
Fuchs, R. T., Curcuru, J. L., Mabuchi, M. Y., Noireterre, A., Weigele, P., Sun, Z., & Robb, G. B. (2022) · Communications Biology · doi:10.1038/s42003-022-03275-2 · Cited by 41
A rapid and inexpensive nucleic acid detection platform for Listeria monocytogenes based on the CRISPR/Cas12a system
Xiao, Y., Ren, H., Wang, H., Zou, D., Liu, Y., Li, H., Hu, P., Li, Y., Liu, Z., & Lu, S. (2023) · Talanta · doi:10.1016/j.talanta.2023.124558 · Cited by 39
Real-Time Observation of Target Search by the CRISPR Surveillance Complex Cascade
Xue, C., Zhu, Y., Zhang, X., Shin, Y., & Sashital, D. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.110 · Cited by 39
Regulation of cyclic oligoadenylate synthesis by the Staphylococcus epidermidis Cas10-Csm complex
Nasef, M., Muffly, M. C., Beckman, A. B., Rowe, S. J., Walker, F. C., Hatoum-Aslan, A., & Dunkle, J. A. (2019) · RNA · doi:10.1261/rna.070417.119 · Cited by 39
Genome-Wide Analyses Revealed Remarkable Heterogeneity in Pathogenicity Determinants, Antimicrobial Compounds, and CRISPR-Cas Systems of Complex Phytopathogenic Genus Pectobacterium
Arizala, D., & Arif, M. (2019) · Pathogens · doi:10.3390/pathogens8040247 · Cited by 39
Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (Mollicutes)
Ipoutcha, T., Τsarmpopoulos, Ι., Talenton, V., Gaspin, C., Moisan, A., Walker, C. A., Brownlie, J., Blanchard, A., Thébault, P., & Sirand‐Pugnet, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02701 · Cited by 41
CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
Lu, J., Liu, J., Guo, Y., Zhang, Y., Xu, Y., & Wang, X. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.007 · Cited by 42
The Application of CRISPR/Cas Systems for Antiviral Therapy
Baddeley, H. J. E., & Isalan, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.745559 · Cited by 41
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs
Rittiner, J. E., Cumaran, M., Malhotra, S., & Kantor, B. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1035543 · Cited by 42
The Mechanisms of Genome Editing Technologies in Crop Plants
Ahmad, Y., Haider, S., Iqbal, J., Abbasi, B. A., Yaseen, T., & Mahmood, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-96925-7_13 · Cited by 40

Authors: Koonin, E. V., Makarova, K. S., & Zhang, F.
Affiliations: United States National Library of Medicine (US)
Broad Institute (US)
Corresponding author: Koonin, Eugene V
ORCID: Koonin, Eugene V
Makarova, Kira S
Zhang, Feng
Venue: Current Opinion in Microbiology
Publisher: Elsevier BV
Published: 2017-06
Volume: 37
Pages: 67-78
ISSN: 1369-5274 (ISSN-L)
DOI: 10.1016/j.mib.2017.05.008
PMC: PMC5776717
OpenAlex: W2623277795
Cited by: 1,423
References: 73
Citations by year: 2026: 70 · 2025: 139 · 2024: 157 · 2023: 136 · 2022: 184 · 2021: 191 · 2020: 178 · 2019: 206 · 2018: 127 · 2017: 33
FWCI: 13.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Current Opinion in Microbiology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
Funders: National Institutes of Health
U.S. National Library of Medicine (Z01LM000073)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords: CRISPR-Cas, adaptive immunity, mobile genetic elements, CRISPR adaptation, comparative genomics
MeSH terms: Archaea, Bacteria, Genetic Variation, Evolution, Molecular, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diversity, classification and evolution of CRISPR-Cas systems

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks